Literature DB >> 2185535

Barriers to the care of persons with dual diagnoses: organizational and financing issues.

M S Ridgely1, H H Goldman, M Willenbring.   

Abstract

Among the frustrations of managing the dual disorders of chronic mental illness and alcohol and drug abuse is the fact that knowing what to do (by way of special programming) is insufficient to address the problem. The system problems are at least as intractable as the chronic illnesses themselves. Organizing and financing care of patients with comorbities is complicated. At issue are the ways in which we administer mental health and alcohol and drug treatment as well as finance that care. Separate administrative divisions and funding pools, while appropriate for political expediency, visibility, and administrative efficiency, have compounded the problems inherent in serving persons with multiple disabilities. Arbitrary service divisions and categorical boundaries at the State level prevent local governments and programs from organizing joint projects or creatively managing patients across service boundaries. When patients cannot adapt to the way services are organized, we risk reinforcing their overutilization of inpatient and emergency services, which are ineffective mechanisms for delivering the care these patients need. This article reviews the barriers in organization and financing of care (categoric and third party financing, including the special problem of diagnosis-related groups limitations) and proposes strategies to enhance the delivery of appropriate treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2185535     DOI: 10.1093/schbul/16.1.123

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  39 in total

1.  Issues and outcomes in integrated treatment programs for dual disorders.

Authors:  J M Jerrell; J L Wilson; D C Hiller
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

2.  New directions in substance abuse services: programmatic innovations in the Veterans Administration.

Authors:  K A Peterson; R W Swindle; R H Moos; J W Finney; R T Suchinsky
Journal:  J Ment Health Adm       Date:  1992

3.  Program development and integrated treatment across systems for dual diagnosis: mental illness, drug addiction, and alcoholism (MIDAA).

Authors:  K Sciacca; C M Thompson
Journal:  J Ment Health Adm       Date:  1996

4.  A call for standardized definition of dual diagnosis.

Authors:  Kathyrn Hryb; Rob Kirkhart; Rebecca Talbert
Journal:  Psychiatry (Edgmont)       Date:  2007-09

5.  Perceived unmet need for alcohol and drug use treatments and future use of services: results from a longitudinal study.

Authors:  Ramin Mojtabai; Rosa M Crum
Journal:  Drug Alcohol Depend       Date:  2012-07-04       Impact factor: 4.492

6.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

7.  Treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuse providers.

Authors:  Virginia Gil-Rivas; Christine E Grella
Journal:  Community Ment Health J       Date:  2005-06

Review 8.  Co-occurring disorders in substance abuse treatment: issues and prospects.

Authors:  Patrick M Flynn; Barry S Brown
Journal:  J Subst Abuse Treat       Date:  2007-06-15

9.  Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines.

Authors:  Astrid Brousselle; Lise Lamothe; Céline Mercier; Michel Perreault
Journal:  Eval Program Plann       Date:  2006-12-26

10.  Balancing accessibility and selectivity in 21st century public mental health services: implications for hard to engage clients.

Authors:  Amy Blank Wilson; Stacey Barrenger; Casey Bohrman; Jeffrey Draine
Journal:  J Behav Health Serv Res       Date:  2013-04       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.